Trevan Locke, PhD
Trevan Locke is an Assistant Research Director at Duke-Margolis working on issues related to biomedical innovation. He oversees Duke-Margolis' involvement as a founding member of the Advancing Clinical Trials at the Point of Care Coalition and workstreams on evidence generation for Duke-Margolis' Real-World Evidence Collaborative. Previously, he worked as a Regulatory Science and Policy Analyst at the American Association for Cancer Research on regulatory issues impacting cancer care and the development of cancer therapies, including considerations for equitable clinical trial enrollment. Dr. Locke completed a Bachelor of Engineering in Chemical and Biomolecular Engineering at Vanderbilt University and a PhD in Chemical and Biochemical Engineering at Rutgers University, where his research focused on the development of nanoparticles for the delivery of chemotherapy to treat cancer.
Trevan Locke, Valerie J. Parker, Andrea Thoumi, Benjamin A. Goldstein, Christina Silcox
Trevan Locke, Rebecca Ray, Rachele Hendricks‐Sturrup, Marianne Hamilton Lopez, Morgan Romine, Mark McClellan
Rebecca Ray, Trevan Locke, Rachele Hendricks-Sturrup
Trevan Locke, Sandra Yankah, Matt D’Ambrosio, Rachele Hendricks-Sturrup
Brian Canter, Trevan Locke, Mark McClellan